Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.

IOZK publication in the International Journal of Molecular Sciences by Prof. Schirrmacher focusing on the role of Newcastle Disease Virus in tumor vaccinations

Portfolio Items